BioCentury
ARTICLE | Politics & Policy

In a first, FDA recognizes genetic database, removing regulatory hurdle

December 4, 2018 11:32 PM UTC

FDA formally recognized for the first time a public genetic database as a valid source of information to support clinical validity in premarket submissions for genetic tests, which could save developers the resources required to collect supporting genetic data.

The agency recognized the database, the ClinGen Expert Curate Human Genetic Data from the NIH-funded consortium Clinical Genome Resources (ClinGen), using criteria outlined in a final guidance issued in April 2018. In the guidance, FDA described its considerations in determining which databases could support clinical validity of a genetic or genomic-based test (see "FDA Streamlining Cancer Diagnostics Development")...